ALHAMBRA, Calif., Dec. 20, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that leadership is presenting at the 41^st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 1:30 p.m. PT/4:30 p.m. ET.

"Being part of the JPM healthcare community for the second year in a row is very exciting to us as a growing team and organization. We're grateful for this opportunity to share our performance and vision with this key investor community and like-minded peers," said Brandon Sim, Co-CEO of ApolloMed. "Our team at ApolloMed is committed to enabling our providers to deliver high quality value-based healthcare to patients and build long-term value for our shareholders."

Leadership will also be participating in one-on-one meetings at this conference, which is taking place January 9-12, 2023, at the Westin St. Francis in San Francisco. The Company's presentation will be made available via live webcast and in archive following the conclusion of the events at the "Events" page of the Company's website: https://www.apollomed.net/news-media/events.

ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.

FOR MORE INFORMATION, PLEASE CONTACT:

Investor Relations
(626) 943-6491 
This email address is being protected from spambots. You need JavaScript enabled to view it.

Carolyne Sohn, The Equity Group
(408) 538-4577
This email address is being protected from spambots. You need JavaScript enabled to view it.